Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions.
about
Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunityReciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathologyEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsThe immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunityRegulation of T helper cell subsets by cyclooxygenases and their metabolitesLipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusCysteinyl leukotrienes: multi-functional mediators in allergic rhinitisMyeloid-derived cells are key targets of tumor immunotherapyRetinoic acid enhances prostaglandin E2 production through increased expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in rat brain microgliaEnvironmental oxygen tension affects phenotype in cultured bone marrow-derived macrophages.Infections and cancer: the "fifty shades of immunity" hypothesis.Soluble iron modulates iron oxide particle-induced inflammatory responses via prostaglandin E(2 )synthesis: In vitro and in vivo studies.In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes.Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in miceThe tumor microenvironment in colorectal carcinogenesis.Proresolving lipid mediators and mechanisms in the resolution of acute inflammationExpression of cyclooxygenase-2 in colorectal cancer and its clinical significance.Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.PPAR and immune system--what do we know?Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni.Inflammasome-mediated inhibition of Listeria monocytogenes-stimulated immunity is independent of myelomonocytic functionCrotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice.Postpartum group a Streptococcus sepsis and maternal immunology.Modulation of the host's immune response by schistosome larvae.Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2.Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors.Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissuesProstanoids and their receptors that modulate dendritic cell-mediated immunity.Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function.Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virusEicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.Topographical and biological evidence revealed FTY720-mediated anergy-polarization of mouse bone marrow-derived dendritic cells in vitro.The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.Gene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer ImmunotherapyEvaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.
P2860
Q26778534-8CF8DF29-1B8B-4247-9C05-45528606E873Q26825075-560B3CF5-5297-4411-94FD-F03590DBA5E3Q26862642-D6C8EC6C-2879-4922-A718-DB281B458E1CQ27014988-3FDA61E1-6B9C-44AB-9B94-820D700827E7Q27021651-EBC91A4B-E8A4-4CF4-B0F6-35989ADDE080Q27026243-FB1BB131-EC7F-4736-BC61-3CA5373D664EQ28080521-BAB800F1-9990-409E-804E-A44639D616FCQ28219122-727B4F20-9A4E-47CF-BDE9-DA03B31DB557Q28388246-635EF294-C152-40C2-BA34-6959380764CFQ28567447-DCA86293-D0BB-44E8-A096-20BDF7AED4F7Q31007378-1AE510E1-B959-4D8C-82BC-04C66BF62E22Q33555975-4954ED13-C79F-4307-9DF8-7A50A8D5811EQ33590029-83B4429F-F652-4462-BFED-AD96A93C2C91Q33714400-65E9CA96-5ACA-485D-94AA-C95D4779E89CQ34055659-F9078CA9-1387-4BFE-A0F1-60A6E6C786D8Q34246553-D210E99D-7E33-46AF-B9E0-D17D179A702FQ34339690-C0F5A7B4-00B3-4193-A988-B63B2EE9E642Q34343645-86018C87-D024-461E-A733-3117BCC72E83Q34411426-789C6D06-BB2A-4FB2-B278-0D465D2061ECQ34605197-EDE53FFA-B72B-420B-8A8F-5DCEB72D4C30Q34760824-483B0040-3B5F-48F2-AC20-913FE8BA4050Q34833647-CB720C19-FB17-4F44-9AE3-6A1899119467Q34913467-842E00FA-22AF-4D20-A535-BF7E5F3D7B40Q35012489-B0D2606E-DAD8-4989-A4E7-A54622EACEBEQ35070801-305BD3FC-4BBD-4806-A90C-C77C8DBCCDACQ35597581-B23E8794-35F0-4106-965A-FE76551177A8Q35658832-712B9AF7-5177-4D81-BC67-D9FC099ACDDEQ35684760-CCBA677B-81CA-4A94-8DF7-D063B0F139E4Q35782203-F23DFD8F-BAD2-4395-AC53-29D10A127C4BQ35793849-520A4776-8E3D-4106-9E10-65C6E93C21CEQ35806803-12A17D50-CA36-42AA-A275-DA52C57CAE84Q35850629-FFFA5C90-0F5F-48DF-9445-19729FB57B31Q35876990-02E815B7-01D6-4AC4-874F-20F0BEFCD83DQ35962511-247AE101-0CF3-4756-A175-0993B59F67A6Q35994233-3C9A2A67-ADE9-44EB-BE21-B41B98D249FEQ36000945-FE6CC7FD-E32D-4875-AEEB-F6E124B6FDDDQ36128812-3C020931-A242-4135-9D5A-C8DEBCBACCFFQ36179801-DEB40253-E614-4E69-9D4D-3A6A5D17A8A9Q36269842-010227E3-31B1-4720-BE13-BBBF1C3DF3F0Q36270342-4333F7E2-7746-4625-83FE-2A4BECA12D17
P2860
Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cyclooxygenase-2-issued prosta ...... ates dendritic cell functions.
@en
Cyclooxygenase-2-issued prosta ...... ates dendritic cell functions.
@nl
type
label
Cyclooxygenase-2-issued prosta ...... ates dendritic cell functions.
@en
Cyclooxygenase-2-issued prosta ...... ates dendritic cell functions.
@nl
prefLabel
Cyclooxygenase-2-issued prosta ...... ates dendritic cell functions.
@en
Cyclooxygenase-2-issued prosta ...... ates dendritic cell functions.
@nl
P2093
P1476
Cyclooxygenase-2-issued prosta ...... ates dendritic cell functions.
@en
P2093
Hedi Harizi
Jean-François Moreau
Monique Juzan
Norbert Gualde
Vincent Pitard
P304
P356
10.4049/JIMMUNOL.168.5.2255
P407
P577
2002-03-01T00:00:00Z